Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

RBI raises loan limits for urban cooperative banks, adjusts real estate exposure norms, and extends deadline for prudential ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.

The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as a first-line therapy for patients with a ...

Higher education institutions are investing in sustainability initiatives, but their specific goals and challenges remain ...

Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...

Minister for Social Security and Disabilities, Sir Stephen Timms also reassured existing PIP claimants with an outstanding ...

Within the last 10-years Liverpool’s Merseyrail has taken huge strides to make the network fully accessible from street to train. Merseyrail installed lifts at several stations across the network, and ...

An independent consulting firm will review the response of Evendale police officers during a neo-Nazi demonstration earlier this month.

With 2025 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care industry this year.

The NRC recently issued Regulatory Issue Summary (RIS) 2025-02, which asks reactor licensees to voluntarily provide information about their plans ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with spinocerebellar ataxia (SCA).